Blood Screening Market is to Witness Market Growth Rate of 9.7% in the Forecast Period of 2018 to 2025

Blood Screening Market is forecasted to grow at 9.7% for 2018 to 2025 with factors such as high cost of technology & instruments and dearth of NAT technology hampering the market growth.

Blood screening market has shown a significant adoption rate and preferences from the North American region with countries such as U.S. and Canada. Rising cases of infectious diseases and increasing prevalence of newer pathogens are some of the factors which will enhance the demand for blood screening market in the region.

Blood Screening Market Scenario

According to Data Bridge Market Research blood screening market in developing regions is witnessing a growth in terms of its adoption rate, due to rising demand for donated blood, increasing cases of infectious diseases, rising healthcare infrastructure and increasing initiatives by government.

Now the question is which are the regions that blood screening market players should target? Data Bridge Market Research has forecasted market leaders to target North American developing regions to help them in attaining better volume of revenue generation.

Blood screening market is becoming more competitive every year with reagents & kits currently being the largest market product & services for the forecasted period of 2018 to 2025. Data Bridge Market Research’s new report highlights the major growth factors and opportunities in the blood screening market.

For more analysis on the blood screening market, request for a briefing with our analysts

Blood Screening Market Development

 Roche announced the launch of their new blood screening test cobbas Zika test in December 2019. This new test is consistent with the cobas 6800/8800 systems, which is designed for use in blood donation screening. This launch will help the company to enhance their reach in the market and also decreases the risk of transmission via plasma donation and infected blood.

Scope of the Blood Screening Market

Blood screening market is segmented into U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

  • All country based analysis of the blood screening market is further analyzed based on maximum granularity into further segmentation. On the basis of product & services, the market is segmented into reagents & kits, instruments and software & services. Based on technology, the market is segmented into enzyme-linked immunosorbent assay, rapid tests, next-generation sequencing, nucleic acid test, western blot assay and others. The disease type segment of the market is divided into oncology, diabetes mellitus, cold & flu, cholesterol, infectious diseases, respiratory diseases, HIV/AIDS, and others. End- user segment of the market is divided into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.
  • Blood screening test is specifically done to various conditions such as cancer and other infections. Different technologies which are used in the blood screening are next generation sequencing, western blot assay, enzyme-linked immunosorbent assay, nucleic acid test and other. The blood screening process is conducted for a number of reasons, with pregnancy, human immunodeficiency (HIV) and blood type screening being the most common reason.

To know more about the study

Key Pointers Covered in the Blood Screening Market Industry Trends and Forecast to 2025

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Bio-Rad Laboratories, Inc.
  • BD
  • Beckman Coulter, Inc.
  • bioMérieux SA
  • Enzo BiochemInc.
  • Hologic Inc.
  • Ortho Clinical Diagnostics
  • Meridian Bioscience, Inc
  • Immucor, Inc.

Above are the key players covered in the report, to know about more and exhaustive list of blood screening companies, contact us

Research Methodology: Global Blood Screening Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@